Ars Pharmaceuticals Inc (SPRY)
Cost of Revenue
$30.53M
TTM · Period ending: · USD
SPRY Cost of Revenue
Latest reported$30.53Mperiod ending
Latest reported$30.53Mperiod ending
SPRY TTM Cost of Revenue ($1.66M → $30.53M)
TTM cost of revenue
High-resolution chart · PNG
SPRY cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 30,525,000 | |
| 22,663,000 | |
| 20,423,000 | |
| 21,113,000 | |
| 13,034,000 | |
| 14,946,000 | |
| 16,134,000 | |
| 15,646,000 | |
| 18,536,000 | |
| 18,848,000 | |
| 20,066,000 | |
| 20,216,000 | |
| 21,007,000 | |
| 18,149,000 | |
| 17,120,000 | |
| 17,480,000 | |
| 18,809,000 | |
| 20,077,500 | |
| 20,273,000 | |
| 16,824,000 | |
| 12,105,000 | |
| 6,887,500 | |
| 1,664,000 |